A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world

por Jang, Dong Hyek, Heo, Seok Jae, Kook, Hyung Don, Lee, Dong Heon, Jung, Hye Jung, Park, Mi Yeon, Ahn, Jiyoung
Publicado 2021

Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study

por Han, Tae Young, Shim, Dong Hyun, Lee, Yu Jin, Lee, Young Bok, Koo, Ha Yeh Rin, Shin, Min Kyung, Kim, Tae Eun, Jang, Yong Hyun, Bang, Jin Seon, Kook, Hyung Don, Ahn, Jiyoung, Jung, Hye Jung, Na, Chan Ho
Publicado 2023